Early-Bird Registration for InnoPharm-2026 Closes Today

Early-bird registration for II edition of Innovations in Pharma R&D(InnoPharm-2026), scheduled to take place in Boston, MA from November 2–4, 2026, is available through today.

InnoPharm-2026 aims to provide a platform for meaningful exchange across the pharmaceutical and biotechnology ecosystem. The program is being developed to reflect current priorities in drug discovery, development, and translational science, with an emphasis on interdisciplinary collaboration. By bringing together perspectives from academia, industry, and regulatory bodies, the conference seeks to facilitate discussions that are both scientifically rigorous and practically relevant.

Participating organizations include Yale School of Medicine, Harvard University, University of California, Boston University, and the U.S. Food and Drug Administration. These institutions represent a broad spectrum of academic and regulatory expertise, contributing to the scientific depth and diversity of the meeting.

In addition to academic and regulatory participation, the conference will include representation from industry organizations such as HitGen Inc., FreeThink Technologies, Inc., DeepCovalent, Inc., and Digital Either Computing. The inclusion of these companies reflects the growing importance of industry-academic partnerships in advancing pharmaceutical innovation, particularly in areas such as computational drug design, formulation science, and early-stage discovery.

Boston, as the host city, offers a well-established ecosystem for life sciences and biotechnology, making it a fitting location for the meeting. The region's concentration of leading academic institutions, research hospitals, and biopharma companies provides an environment conducive to collaboration and exchange. Hosting the conference in Boston is expected to further support engagement among participants and facilitate connections within this broader innovation network.

InnoPharm-2026 is also intended to provide opportunities for early-career researchers and emerging professionals to engage with established experts in the field. Through presentations, panel discussions, and networking sessions, attendees will have the opportunity to explore new ideas, share their work, and build connections that may extend beyond the conference itself. The format is designed to encourage dialogue across experience levels and sectors, contributing to a more inclusive and dynamic exchange of ideas.

Individuals planning to attend are encouraged to complete their registration prior to the close of the early-bird period. Registration details and additional information about the conference program are available at:
https://pharm-science.com/register

Further updates regarding the agenda, speakers, and session topics will be shared in the coming months as the program continues to develop.

See you in Boston.

Contact
Gayatri Srinivas
Conference Manager